Artificial ventilation and anesthesia masks market seen reaching $3.18 billion by 2030

The artificial ventilation and anesthesia masks market is projected to grow from $2.48 billion in 2026 to $3.18 billion by 2030, driven by rising respiratory disease cases, more surgeries and expanding ICU and operating room capacity. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Artificial ventilation and anesthesia masks are core tools for respiratory support in surgery, intensive care and emergency care. - Market growth reflects rising demand for devices that can deliver oxygen, air or anesthetic gases safely and consistently. - Expanding use matters as healthcare systems face more respiratory disease, more procedures and more pressure on ICU capacity.

What happened: - The Business Research Company projected the artificial ventilation and anesthesia masks market will rise from $2.48 billion in 2026 to $3.18 billion by 2030. - The forecast implies a 6.4% compound annual growth rate over the period. - The market had been estimated at $2.32 billion in 2025 and $2.48 billion in 2026, reflecting 6.9% growth. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the next several years. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the report is available. - The full market report is also available.

The details: - The market’s historical growth has been tied to limited availability of advanced ventilation devices, rising surgical volumes, ICU buildouts, increasing respiratory disorders and demand for reusable mask solutions. - Future growth is expected to come from improvements in non-invasive and invasive ventilation systems. - Adoption of homecare and ambulatory respiratory services is expected to add demand. - An aging population is expected to support market expansion. - Demand for disposable masks is rising as providers look to reduce cross-contamination. - Operating room and ICU expansion worldwide is expected to support sales. - Artificial ventilation and anesthesia masks are designed to cover the nose and mouth and create a seal for oxygen, ambient air or anesthetic gas delivery. - The masks are used to support or fully manage breathing during procedures, in intensive care units and in emergency situations. - The report highlights market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables.

Between the lines: - The forecast points to a market moving from broad hospital use toward a wider mix of care settings, including home and ambulatory care. - Rising use of disposable masks suggests infection control and patient safety are becoming more important purchasing factors. - The regional outlook suggests mature demand in North America and faster opportunity in Asia-Pacific as healthcare infrastructure expands. - UK health data cited in the release showed emergency admissions for respiratory diseases in England rose 7% between the financial years ending 2023 and 2024. - Within that increase, COPD admissions rose 9%, adult asthma 17% and pneumonia 16%. - Higher respiratory admissions add pressure on clinical settings that rely on ventilation and anesthesia masks.

What’s next: - Growth through 2030 will likely track the pace of respiratory disease burden, surgical demand and ICU investment. - Product development should remain focused on ventilation performance, disposable designs and care-setting flexibility. - Regional gains will likely depend on infrastructure spending and adoption in both hospital and non-hospital respiratory care.

The bottom line: - The market is still expanding, and the biggest drivers are basic healthcare needs: breathing support, surgery and respiratory disease management.